搜索临床试验以:丙酸氟替卡松_1.5
总计683个结果
-
GlaxoSmithKline完全的肺部疾病,慢性阻塞性美国, 德国, 西班牙, 荷兰, 加拿大
-
University of ChicagoGlaxoSmithKline完全的
-
University of ChicagoGlaxoSmithKline完全的
-
Makerere UniversityUniversity of Copenhagen完全的
-
Xijing Hospital未知
-
Optinose US Inc.完全的
-
MEDA Pharma GmbH & Co. KGClinResearch, GmbH; Prolytic GmbH; pharm-analyt GmbH完全的
-
Teva Branded Pharmaceutical Products R&D, Inc.完全的
-
Mundipharma Research Limited完全的
-
Far Eastern Memorial HospitalResearch Ethics Review Committee未知
-
Taipei Veterans General Hospital, TaiwanNational Taiwan University Hospital; Far Eastern Memorial Hospital未知
-
Teva Branded Pharmaceutical Products R&D, Inc.完全的
-
Mundipharma (China) Pharmaceutical Co. Ltd未知
-
GlaxoSmithKline撤销
-
Children's Hospital of PhiladelphiaNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
ORA, Inc.完全的
-
University of Wisconsin, MadisonUniversity of California, San Diego; National Heart, Lung, and Blood Institute (NHLBI); National... 和其他合作者完全的
-
University of California, San FranciscoSandler Family Supporting Foundation完全的
-
Queen Mary University of LondonGlaxoSmithKline; British Lung Foundation完全的
-
Leiden University Medical CenterGlaxoSmithKline; Academisch Ziekenhuis Groningen; Netherlands Organisation for Scientific Research 和其他合作者终止
-
SanofiRegeneron Pharmaceuticals完全的